There was a trend for a greater risk of HFS in African-American/non-Hispanic (OR 2.26, 95%CI 0.86-5.95; P=0.09), although this result did not reach statistical significance ( Table 3 ).
← all excerpts
Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers.
1
—
—